Every Great Idea Deserves To Be A Successful Business
Ikove unlocks the potential of technology commercialization by identifying and vetting disruptive technologies at leading research labs and launching those into successful startups that deserve to be shared with humanity.
How we’ve grown
Our performance, from our founding in 2014 to the present:
A Significant Capital Gap Exists Between University Funded R&D and VC Funded Rounds
Universities & research institutions spend over $90 billion a year in R&D, but less than 1% is invested in commercialization efforts.
Unicorn share of venture investing has skyrocketed while early stage deals have been cut in half, ~2% of all venture deals received close to 40% of all money invested in venture.
Revolutionary IP is left sitting on the shelves at leading universities, Upwards of 95% of patented university innovations go unfunded and never reach commercial market.
The Startup Nursery Fund allows external, strategic investors to co-invest alongside Ikove’s Nursery.
Ikove’s Startup Nursery creates businesses around the best intellectual property funded through the research budget of leading universities.
Investors can now capitalize on exclusive opportunities related to the commercialization of disruptive intellectual property and startup companies.
We pursue early-stage investments with an emphasis on technology commercialization
Through our proprietary Startup Nursery, in partnership with multiple U.S. research institutions, We identify and validate developing high-impact technologies, providing capital and commercialization resources to bridge the gap between R&D and VC funded rounds.
